Physician profile
Ashraf Ragab
NPI 1851387476
$2,103.40
in general payments reported to CMS, 2019-2025
15 companies · $87.52 in 2025
The $87.52 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $381 · 2020: $421 · 2021: $50.09 · 2022: $799 · 2023: $293 · 2024: $71.34 · 2025: $87.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $452.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $452.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corelink, LLC | $784.90 | 2021-2023 | |
| Abbott Laboratories | $747.83 | 2019-2023 | Proclaim |
| Boston Scientific Corporation | $271.89 | 2022-2024 | Wavewriter Alpha Prime 16 |
| Foundation Fusion Solutions, LLC | $87.52 | 2025 | |
| Mvp Orthopedics INC | $43.97 | 2022 | |
| Idorsia Pharmaceuticals US INC | $22.74 | 2024 | Quviviq |
| Baxter Healthcare | $22.53 | 2019 | |
| Electronic Waveform Lab, INC. | $19.38 | 2019 | |
| Theragen, INC. | $17.73 | 2023 | Actastim-S |
| Medela LLC | $17.24 | 2020 | |
| Orthofix Medical, INC. | $15.25 | 2020 | |
| Nalu Medical, INC. | $14.91 | 2021 | |
| Providence Medical Technology, INC. | $13.65 | 2021 | |
| Bioventus LLC | $12.47 | 2020 | |
| Medtronic USA, INC. | $11.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashraf Ragab listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.